Skip to main content
. 2021 Aug 26;12:728082. doi: 10.3389/fimmu.2021.728082

Figure 7.

Figure 7

Targeting Brd4 with inhibitors dampens effector CD8+ T cells-mediated antiviral immunity. (A) Experiment design. (B) Flow cytometry showing the expression of CD8 (left), the quantification of total CD8+ T cells (middle) and the quantification of LCMVgp33 epitope-specific CD8+ T cell numbers (right). (C) Flow cytometry showing the expression of KLRG1 and CD127 in LCMVgp33 epitope-specific CD8+ T cells from mice treated with JQ1 or DMSO at day 8 post-infection (left) and the frequency and number of each subset (right). (D, E) Flow cytometry analysis of indicated cytokines production after peptide stimulation in CD8+ T cells from mice treated with JQ1 or DMSO (left) and the number and frequency (right) of cytokine-producing CD8+ T cells. The data were analyzed by two-tailed unpaired t-test between two independent groups. Results were indicated as mean ± sem (error bars). *p < 0.05; **p < 0.01; ***p < 0.001. Each group includes at least 4 mice and each experiment repeats more than 2 times.